Product Program year 2023 Source: CMS Open Payments

Suvecaltamide

Open in the dashboard

General payments

$3,554

36 payments

Research payments

$0

0 payments

Through program year 2023, $3,554 in general payments and $0 in research payments were reported against Suvecaltamide.

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

1 row
Year Kind Amount Payments
2023 General $3,554 36

Breakdown

Who paid General payments · program year 2023
  1. Jazz Pharmaceuticals Inc. $3,554 36 payments
Top recipients General payments · program year 2023
  1. Jeri Williams Neurology · Bakersfield, CA $1,800 51% · 2 payments
  2. Mark Gudesblatt Neurology · Islip, NY $391 11% · 7 payments
  3. Stuart Isaacson Neurology · Boca Raton, FL $297 8% · 3 payments
  4. Mark Goldstein Neurology · Atlantis, FL $258 7% · 2 payments
  5. Theresa Zesiewicz Neurology · Tampa, FL $229 6% · 5 payments

The top 5 of 14 recipients; each share is of general payments naming this product in 2023.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2023
  1. Neurology Psychiatry & Neurology $3,174 89% · 7 practitioners
  2. Pulmonary Disease Internal Medicine $161 5% · 3 practitioners
  3. Internal Medicine $138 4% · 1 practitioner
  4. Nurse Practitioner, Gerontology Nurse Practitioner $37 1% · 1 practitioner
  5. Physician Assistant $22 <1% · 1 practitioner

The top 5 of 6 specialties; each share is of general payments naming this product to practitioners with a specialty in 2023. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2023
  1. California $1,800 51% · 1 recipient
  2. Florida $921 26% · 4 recipients
  3. New York $391 11% · 1 recipient
  4. South Carolina $220 6% · 5 recipients
  5. Illinois $138 4% · 1 recipient

The top 5 of 7 states; each share is of general payments naming this product in 2023 where a state was reported.

The top 25 states, free in the app

36 general

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2023

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record